Lifeboat Foundation

The startup has an incredibly ambitious plan for the future.

But Microsoft still has a lot of work to do.

Prostate cancer remains one of the major causes of death worldwide. In view of the limited treatment options for patients with prostate cancer, preventive and treatment approaches based on natural compounds can play an integral role in tackling this disease. Recent evidence supports the beneficial effects of plant-derived phytochemicals as chemopreventive and chemotherapeutic agents for various cancers, including prostate cancer. Prunus africana has been used for generations in African traditional medicine to treat prostate cancer. This review examined the potential roles of the phytochemicals from P. africana, an endangered, sub-Saharan Africa plant in the chemoprevention and chemotherapy of prostate cancer. In vitro and in vivo studies have provided strong pharmacological evidence for antiprostate cancer activities of P. africana-derived phytochemicals. Through synergistic interactions between different effective phytochemicals, P. africana extracts have been shown to exhibit very strong antiandrogenic and antiangiogenic activities and have the ability to kill tumor cells via apoptotic pathways, prevent the proliferation of prostate cancer cells, and alter the signaling pathways required for the maintenance of prostate cancer cells. However, further preclinical and clinical studies ought to be done to advance and eventually use these promising phytochemicals for the prevention and chemotherapy of human prostate cancer.

Prostate cancer is one of the most common nonskin cancers in men. It is caused by unregulated prostate cell division, which leads to abnormal growth, with the potential to spread to other parts of the body [1]. These neoplastic cells originate from highly specialized cells through a process of regression to an advanced stage. Unlike the normal parent cells, these cells divide continuously, resulting in a tumor. Approximately, 9–11% of men are at risk of clinically suffering from prostate cancer in their life time [2–5]. Prostate cancer is typically androgen-dependent during its initial stages when the hormone androgen binds to the androgen receptor (AR) and then transactivates target genes [6, 7]. Androgen and AR-mediated signaling are therefore crucial for the development and functioning of both the normal prostate and prostate cancer.

The future is just over the horizon and we’re accelerating towards it. And while the famous Dr. Emmett Brown from Back to the Future once said, “Where we’re going, we don’t need roads,” at this year’s Consumer Electronics Show (CES), Nissan revealed not only the future of road-based transportation but equally your future whip.

Driving in the future will not only be autonomous, but will also seamlessly integrate the virtual world into your physical domain using mixed reality, creating an all-around intelligent, connected, transportation ecosystem.

Continue reading “Nissan Reveals Invisible Tech for a Visible Future at CES” »

Although it’s impossible (at least for now) to travel back in time to see the Big Bang, The New York Times has provided its readers the closest simulation of the experience via its latest augmented reality feature.

On Friday, the Times published “It’s Intermission for the Large Hadron Collider,” an interactive story that gives readers a virtual tour of the Large Hadron Collider at the European Center for Nuclear Research (CERN) in Switzerland and explores its most famous discovery, the Higgs boson.

Lockheed Martin engineers wear the goggles to help them assemble the crew capsule Orion—without having to read thousands of pages of paper instructions.

Augmented Reality (AR), Virtual Reality (VR), Mixed Reality (MR), Haptics and Holographics, are all in gradual market diffusion stage as of 2018, after having long been the stuff of science fiction content. Even so, even as of 2018, the misconceptions remains overwhelmingly widespread and strong, that these are for gaming, entertainment, leisure and recreation. None of these technologies or interface methods, however, were ever meant to be for just that alone.

The military plans to purchase as many as 100,000 HoloLens augmented reality devices.

Mounting an augmented reality device to a surgeon’s head — pioneering new research promises to save thousands of lives by merging classic techniques with modern technology.

At Pisa’s University, in Italy, researchers of the Vostars project, are working to develop a new kind of surgical visor in a bid to improve accuracy of interventions and reducing surgery times by at least 11%.

“The reality is of course the operating field, the anatomy that is in front of the surgeon; on this reality, we insert a virtual information that is acquired from the radiological images of the same patient. ”explained Vincenzo Ferrari, a biomedical engineer turned project coordinator for Vostars.

Continue reading “Augmented Reality to Change Surgery Techniques” »